Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: Focus on adenosine, nitric oxide and mitochondrial ATP‐sensitive potassium channels

1. The present study examined whether or not cilostazol reduces the myocardial infarct size, and investigated its mechanism in a rabbit model of myocardial infarction.

[1]  M. Lewis,et al.  Endothelium‐derived relaxing factor inhibits in vitro platelet aggregation , 1987, British journal of pharmacology.

[2]  M. Arai,et al.  Infarct size-reducing effect of ischemic preconditioning is related to alpha1b-adrenoceptors but not to alpha1a-adrenoceptors in rabbits. , 1997, Journal of cardiovascular pharmacology.

[3]  R. Bolli,et al.  Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. , 1998, Circulation.

[4]  C. Thiemermann,et al.  Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate. , 1996, Cardiovascular research.

[5]  Sheng Wang,et al.  Inhibition of adenosine uptake and augmentation of ischemia-induced increase of interstitial adenosine by cilostazol, an agent to treat intermittent claudication. , 2000, Journal of cardiovascular pharmacology.

[6]  R. Bolli.  Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). , 1988, Journal of the American College of Cardiology.

[7]  M. Arai,et al.  Benidipine Reduces Myocardial Infarct Size Involving Reduction of Hydroxyl Radicals and Production of Protein Kinase C-Dependent Nitric Oxide in Rabbits , 2004, Journal of cardiovascular pharmacology.

[8]  J. Downey,et al.  Protection Against Infarction Afforded by Preconditioning is Mediated by A1 Adenosine Receptors in Rabbit Heart , 1991, Circulation.

[9]  W. Hiatt.  Pharmacologic therapy for peripheral arterial disease and claudication. , 2002, Journal of vascular surgery.

[10]  J. Downey,et al.  Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. , 1995, Circulation research.

[11]  M. Arai,et al.  A novel anti‐diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits , 1999, British journal of pharmacology.

[12]  Yigang Wang,et al.  Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. , 1999, Circulation research.

[13]  Yongge Liu,et al.  Cilostazol as a unique antithrombotic agent. , 2003, Current pharmaceutical design.

[14]  木村 征夫.  Effect of cilostazol on platelet aggregation and experimental thrombosis , 1988 .

[15]  J. Vane,et al.  Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Shinohara,et al.  Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[17]  B. Davidson,et al.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. , 1998, Circulation research.

[18]  D. McAdoo,et al.  The Cardioprotective Effect of a Statin and Cilostazol Combination: Relationship to Akt and Endothelial Nitric Oxide Synthase Activation , 2007, Cardiovascular Drugs and Therapy.

[19]  A. M. Lefer,et al.  Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. , 1993, Circulation research.

[20]  L. Horwitz,et al.  Dimethylthiourea, but not dimethylsulfoxide, reduces canine myocardial infarct size. , 1989, Free radical biology & medicine.

[21]  K. Shimamoto,et al.  Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. , 1992, Cardiovascular research.

[22]  M. Hori,et al.  A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. , 1999, Journal of the American College of Cardiology.

[23]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[24]  M. Arai,et al.  Infarct Size-Reducing Effect of Ischemic Preconditioning Is Related to α1b-Adrenoceptors But Not to α1a-Adrenoceptors in Rabbits , 1997 .

[25]  R. Busse,et al.  Generation of nitric oxide by human neutrophils. , 1989, Biochemical and biophysical research communications.

[26]  J. Downey,et al.  Ischemic preconditioning: from adenosine receptor to KATP channel. , 2000, Annual review of physiology.

[27]  T. Vanden Hoek,et al.  ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. , 2003, American journal of physiology. Heart and circulatory physiology.

[28]  M. Arai,et al.  Quinaprilat Reduces Myocardial Infarct Size Involving Nitric Oxide Production and Mitochondrial KATP Channel in Rabbits , 2003, Journal of cardiovascular pharmacology.

[29]  Y. Ohashi,et al.  Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial , 2010, The Lancet Neurology.

[30]  R. Weisbrod,et al.  Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery. , 1988, The American journal of physiology.

[31]  K. Utsumi,et al.  Cross-talk between NO and oxyradicals, a supersystem that regulates energy metabolism and survival of animals , 2000, Free radical research.

[32]  R. Lassila,et al.  Peripheral arterial disease--natural outcome. , 2009, Acta medica Scandinavica.

[33]  T. Tani,et al.  Effect of cilostazol on platelet aggregation and experimental thrombosis. , 1985, Arzneimittel-Forschung.

[34]  P. Tsao,et al.  Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. , 1994, Circulation.

[35]  Kortaro Tanaka,et al.  Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia. , 1989, Stroke.

[36]  G. Gross,et al.  Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. , 1992, Circulation research.